These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 32523115)
21. Interleukin-15: new kid on the block for antitumor combination therapy. Van den Bergh JM; Van Tendeloo VF; Smits EL Cytokine Growth Factor Rev; 2015 Feb; 26(1):15-24. PubMed ID: 25306466 [TBL] [Abstract][Full Text] [Related]
23. Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma. Nakano H; Kishida T; Asada H; Shin-Ya M; Shinomiya T; Imanishi J; Shimada T; Nakai S; Takeuchi M; Hisa Y; Mazda O J Gene Med; 2006 Jan; 8(1):90-9. PubMed ID: 16097036 [TBL] [Abstract][Full Text] [Related]
24. Killers at the crossroads: The use of innate immune cells in adoptive cellular therapy of cancer. Sabry M; Lowdell MW Stem Cells Transl Med; 2020 Sep; 9(9):974-984. PubMed ID: 32416056 [TBL] [Abstract][Full Text] [Related]
25. NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer. Smyth MJ; Swann J; Kelly JM; Cretney E; Yokoyama WM; Diefenbach A; Sayers TJ; Hayakawa Y J Exp Med; 2004 Nov; 200(10):1325-35. PubMed ID: 15545356 [TBL] [Abstract][Full Text] [Related]
26. IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy. Weber R; Groth C; Lasser S; Arkhypov I; Petrova V; Altevogt P; Utikal J; Umansky V Cell Immunol; 2021 Jan; 359():104254. PubMed ID: 33296753 [TBL] [Abstract][Full Text] [Related]
27. Natural killer cells as a double-edged sword in cancer immunotherapy: A comprehensive review from cytokine therapy to adoptive cell immunotherapy. Wu Y; Li J; Jabbarzadeh Kaboli P; Shen J; Wu X; Zhao Y; Ji H; Du F; Zhou Y; Wang Y; Zhang H; Yin J; Wen Q; Cho CH; Li M; Xiao Z Pharmacol Res; 2020 May; 155():104691. PubMed ID: 32070721 [TBL] [Abstract][Full Text] [Related]
28. Bench to bedside: NK cells and control of metastasis. Krasnova Y; Putz EM; Smyth MJ; Souza-Fonseca-Guimaraes F Clin Immunol; 2017 Apr; 177():50-59. PubMed ID: 26476139 [TBL] [Abstract][Full Text] [Related]
29. Harnessing Natural Killer Cell Antitumor Immunity: From the Bench to Bedside. Woan KV; Miller JS Cancer Immunol Res; 2019 Nov; 7(11):1742-1747. PubMed ID: 31676567 [TBL] [Abstract][Full Text] [Related]
30. Common gamma chain cytokines in combinatorial immune strategies against cancer. Pulliam SR; Uzhachenko RV; Adunyah SE; Shanker A Immunol Lett; 2016 Jan; 169():61-72. PubMed ID: 26597610 [TBL] [Abstract][Full Text] [Related]
31. NK Cell-Mediated Antitumor Effects of a Folate-Conjugated Immunoglobulin Are Enhanced by Cytokines. Jaime-Ramirez AC; McMichael E; Kondadasula S; Skinner CC; Mundy-Bosse BL; Luedke E; Jones NB; Mani A; Roda J; Karpa V; Li H; Li J; Elavazhagan S; La Perle KM; Schmitt AC; Lu Y; Zhang X; Pan X; Mao H; Davis M; Jarjoura D; Butchar JP; Poi M; Phelps M; Tridandapani S; Byrd JC; Caligiuri MA; Lee RJ; Carson WE Cancer Immunol Res; 2016 Apr; 4(4):323-336. PubMed ID: 26865456 [TBL] [Abstract][Full Text] [Related]
32. IL-21 Signaling in the Tumor Microenvironment. Chabab G; Bonnefoy N; Lafont V Adv Exp Med Biol; 2020; 1240():73-82. PubMed ID: 32060889 [TBL] [Abstract][Full Text] [Related]
33. NK cell-based immunotherapy for cancer. Fang F; Xiao W; Tian Z Semin Immunol; 2017 Jun; 31():37-54. PubMed ID: 28838796 [TBL] [Abstract][Full Text] [Related]
34. Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors. Lu S; Zhang J; Liu D; Li G; Staveley-O'Carroll KF; Li Z; Wu JD Clin Cancer Res; 2015 Nov; 21(21):4819-30. PubMed ID: 26106076 [TBL] [Abstract][Full Text] [Related]
36. Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system. Sampson JH; Archer GE; Ashley DM; Fuchs HE; Hale LP; Dranoff G; Bigner DD Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10399-404. PubMed ID: 8816812 [TBL] [Abstract][Full Text] [Related]
37. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy. Gaggero S; Witt K; Carlsten M; Mitra S Front Immunol; 2020; 11():621225. PubMed ID: 33584718 [TBL] [Abstract][Full Text] [Related]
38. Melittin-MIL-2 fusion protein as a candidate for cancer immunotherapy. Liu M; Wang H; Liu L; Wang B; Sun G J Transl Med; 2016 Jun; 14(1):155. PubMed ID: 27246873 [TBL] [Abstract][Full Text] [Related]
39. Insufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cells. Littwitz-Salomon E; Dittmer U; Sutter K Retrovirology; 2016 Nov; 13(1):77. PubMed ID: 27821119 [TBL] [Abstract][Full Text] [Related]